Britain reported that it has secured access to 90 million doses of potential coronavirus vaccines in deals with biotech firms BioNTech, Pfizer and Valneva.
Business Secretary Alok Sharma said Britain would now have access to three different types of vaccines being developed domestically and around the world, and it had also launched a website for volunteers to sign up for vaccine studies.
Alok Sharma said “The hunt to find a vaccine is a truly global endeavour and we are doing everything we can to ensure the British public get access to a safe and effective coronavirus vaccine as soon as possible.”
The deals involve 30 million doses of a vaccine being developed by BioNTech and German firm Pfizer, and 60 million doses of another created by France’s Valneva.
The government has already said it would purchase 100 million doses of a vaccine currently being trialed by Oxford University in partnership with AstraZeneca.
Health Secretary, Matt Hancock, said an effective vaccine was their best hope of defeating coronavirus and returning to life as normal.
Comments are closed.